Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai, Inc. reports recurring developments in healthcare technology, third-party administration and pharmacy benefit management services for employers that directly fund employee health benefits. The company operates subsidiaries that provide TPA, PBM and value-oriented health plan services, including the MarpaiRx pharmacy benefit platform and the Marpai Saves initiative.
News about MRAI commonly covers MarpaiRx client wins, marketing collaborations, network access arrangements with providers such as Aetna and Cigna, financial results, operating efficiency initiatives and leadership changes tied to its health benefits administration business.
Marpai (OTCQX:MRAI) reported Q1 2026 net revenue of $4.4 million, down from $5.4 million a year earlier, with total costs and expenses reduced about 10% to $6.9 million. Operating loss was $2.5 million and net loss $3.2 million or $(0.13) per share.
The company is nearing completion of a unified cloud-based platform expected to lower IT and staffing costs from Q2 2026. Marpai highlighted a MarpaiRx marketing agreement giving potential access to about 1.5 million employee lives and a JGB debt amendment that reduces near-term cash outlays. Management targets company-wide run-rate profitability in the second half of 2026.
Marpai (OTCQX:MRAI) announced multiple new client wins across its core TPA and MarpaiRx PBM divisions, spanning diverse self-insured employer groups. These contracts are expected to expand the member base and be key drivers toward profitability and positive operating cash flow.
The agreements include comprehensive TPA, integrated pharmacy benefit management, and coordinated healthcare solutions that combine medical optimization, cost containment, and proactive member services, supporting Marpai’s data-driven, transparency-focused healthcare offering.
Marpai (OTCQX: MRAI) announced a three-year definitive marketing agreement to scale MarpaiRx PBM services via a large healthcare solutions provider affiliate network. The company called it its largest to date, aiming to expand access to self-insured employer groups and accelerate progress toward positive operating cash flow and profitability. The agreement mandates full data transparency including itemized rebate and drug-spend reporting.
Marpai (OTCQX: MRAI) executed a marketing agreement on March 9, 2026 that gives MarpaiRx potential access to a network representing up to 1.5 million covered lives. The deal creates a national distribution channel to introduce PBM, TPA, analytics, and consulting services to large employers and third-party administrators.
Marpai says its MarpaiRx platform is built to scale and expects the partnership to expand its addressable market, create a pipeline of new business opportunities, and support recurring, per-member revenue as lives are onboarded.
Marpai (OTCQX:MRAI) announced two strategic MarpaiRx client wins on Feb 23, 2026, adding >19,000 covered lives and accelerating platform expansion.
Both implementations are expected to be fully operational early in Q2 2026, expand rebate management and TPA services, and reinforce adoption by health plan consultants and brokers.
Marpai (OTCQX: MRAI) announced the hire of Mimi Davis as President of MarpaiRx on January 27, 2026. Davis joins from Knipper Health, bringing prior leadership at Eagle Pharmacy and extensive experience in Pharmacy Benefit Management and retail pharmacy operations. She will oversee strategic expansion, operational scaling, and efforts to streamline pharmacy operations while enhancing MarpaiRx's value proposition. Management says Davis will support growth and integration of Marpai's technology and clinical insights to deliver cost-effective pharmacy benefits to members and clients.
Marpai (OTCQX: MRAI) announced renewal of its access to the Aetna Signature Administrator (ASA) PPO network and integration of the Aetna Faircost Optimizer, while reporting a better-than-expected 2026 sales cycle with new clients effective January 1, 2026. The ASA renewal preserves broad national provider access and competitive network discounts for Marpai's self-funded employer clients, maintaining continuity of care. The Faircost Optimizer adds an integrated tool to manage out-of-network claims and limit balance-billing exposure. Management describes the combination of enhanced network access and cost-containment tools as reinforcing Marpai's path to scalable growth and previously guided profitability targets for 2026.
Marpai (OTCQX:MRAI) reported third quarter 2025 results showing continued turnaround progress and positioning for growth in 2026. For the quarter ended September 30, 2025 the company reported a 24% reduction in operating expenses (from $5.0 to $3.8, ~ $1.2 million saved), a 9% narrower operating loss (from $3.1 million to $2.8 million), and a 2% improvement in net loss (from $3.6 million to $3.5 million). EPS improved by $0.10. Marpai closed a $3.9 million PIPE to support the turnaround and noted double‑digit new clients contracted for January 1. Management reiterated a target of achieving profitability in Q1 2026 and highlighted automation, PBM integration, and claims management as strategic priorities.
Marpai (OTCQX: MRAI) will host a conference call and webcast on Thursday, November 13, 2025 at 8:30 a.m. ET to discuss third quarter 2025 operational and financial highlights. The company will report Q3 2025 results on the Wednesday after market close prior to the call. Investors can join by phone (US: 1-646-357-8785; Toll Free: 1-800-836-8184) or via webcast at https://app.webinar.net/934VMynbB6a. A replay will be available at the same webcast URL within two hours after the call and by phone through November 20, 2025 using replay code 79452#.
Marpai (OTCQX: MRAI) was recognized as a Top Health Plan Third Party Administrator for 2025 by Insurance Business Review Magazine on October 14, 2025.
The award cites Marpai's technology-driven model emphasizing Smarter Tools, Better Care, and Real Savings, its focus on anticipating high-cost events, and its role beyond claims processing in the $150 billion TPA sector. The selection followed nominations and an evaluation by an expert panel of C-level executives, industry leaders, and the magazine's editorial board. Management said the accolade validates the company’s innovation and value proposition for clients and members.